DKA Risk Similar Across Kidney Function Levels in Type 1 Diabetes Tags Diabetic ketoacidosis SGLT-2 Inhibitor Read more about DKA Risk Similar Across Kidney Function Levels in Type 1 Diabetes
Gout Medication Use Lower Among T2DM Patients Using SGLT2 Inhibitors Tags GLP-1 agonists DPP-4 inhibitors SGLT-2 Inhibitor Read more about Gout Medication Use Lower Among T2DM Patients Using SGLT2 Inhibitors
Canagliflozin Modifies Sodium-Heart Failure Risk Pattern in T2DM-CKD Tags Coronary artery disease SGLT-2 Inhibitor Read more about Canagliflozin Modifies Sodium-Heart Failure Risk Pattern in T2DM-CKD
GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM Tags Coronary artery disease Stroke GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM
Recurrent Ischemic Stroke Lower With SGLT2i in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Stroke Read more about Recurrent Ischemic Stroke Lower With SGLT2i in T2DM
OAC Risk Similar With SGLT2i and DPP4i in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about OAC Risk Similar With SGLT2i and DPP4i in T2DM
Canagliflozin Reduces Myocardial Fibrosis on CMR in T2DM Tags MRI Chest Myocardial infarction hBA1c SGLT-2 Inhibitor Read more about Canagliflozin Reduces Myocardial Fibrosis on CMR in T2DM
GLP-1RAs Rarely Used as Early Therapy in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1RAs Rarely Used as Early Therapy in T2DM
Salt-Related BP Changes Differ With SGLT2 Therapy Tags SGLT-2 Inhibitor Read more about Salt-Related BP Changes Differ With SGLT2 Therapy
AF Patients on OAC Show Higher Erythrocytosis With SGLT2 Inhibitors Tags SGLT-2 Inhibitor Read more about AF Patients on OAC Show Higher Erythrocytosis With SGLT2 Inhibitors